BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 22229339)

  • 1. Cardiac aging: from molecular mechanisms to significance in human health and disease.
    Dai DF; Chen T; Johnson SC; Szeto H; Rabinovitch PS
    Antioxid Redox Signal; 2012 Jun; 16(12):1492-526. PubMed ID: 22229339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Good at Heart: Preserving Cardiac Metabolism during aging.
    Sorriento D; Franco A; Rusciano MR; Maione AS; Soprano M; Illario M; Iaccarino G; Ciccarelli M
    Curr Diabetes Rev; 2015; 12(2):90-9. PubMed ID: 26201429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria and cardiovascular aging.
    Dai DF; Rabinovitch PS; Ungvari Z
    Circ Res; 2012 Apr; 110(8):1109-24. PubMed ID: 22499901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac aging in mice and humans: the role of mitochondrial oxidative stress.
    Dai DF; Rabinovitch PS
    Trends Cardiovasc Med; 2009 Oct; 19(7):213-20. PubMed ID: 20382344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria and oxidative stress in heart aging.
    Martín-Fernández B; Gredilla R
    Age (Dordr); 2016 Aug; 38(4):225-238. PubMed ID: 27449187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human kallikrein overexpression alleviates cardiac aging by alternatively regulating macrophage polarization in aged rats.
    Hu D; Dong R; Yang Y; Chen Z; Tang Y; Fu M; Wang DW; Xu X; Tu L
    FASEB J; 2019 Jul; 33(7):8436-8452. PubMed ID: 30995868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective Effects of Curcumin in Cardiovascular Diseases-Impact on Oxidative Stress and Mitochondria.
    Cox FF; Misiou A; Vierkant A; Ale-Agha N; Grandoch M; Haendeler J; Altschmied J
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging.
    Dai DF; Santana LF; Vermulst M; Tomazela DM; Emond MJ; MacCoss MJ; Gollahon K; Martin GM; Loeb LA; Ladiges WC; Rabinovitch PS
    Circulation; 2009 Jun; 119(21):2789-97. PubMed ID: 19451351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTOR signalling: the molecular interface connecting metabolic stress, aging and cardiovascular diseases.
    Yang Z; Ming XF
    Obes Rev; 2012 Dec; 13 Suppl 2():58-68. PubMed ID: 23107260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial oxidative stress and cardiac ageing.
    Martín-Fernández B; Gredilla R
    Clin Investig Arterioscler; 2018; 30(2):74-83. PubMed ID: 29398015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance: an additional risk factor in the pathogenesis of cardiovascular disease in type 2 diabetes.
    Patel TP; Rawal K; Bagchi AK; Akolkar G; Bernardes N; Dias DDS; Gupta S; Singal PK
    Heart Fail Rev; 2016 Jan; 21(1):11-23. PubMed ID: 26542377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Aging Heart.
    Chiao YA; Rabinovitch PS
    Cold Spring Harb Perspect Med; 2015 Sep; 5(9):a025148. PubMed ID: 26328932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Mitochondrial Approach to Cardiovascular Risk and Disease.
    Veloso CD; Belew GD; Ferreira LL; Grilo LF; Jones JG; Portincasa P; Sardão VA; Oliveira PJ
    Curr Pharm Des; 2019; 25(29):3175-3194. PubMed ID: 31470786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postinfarction exercise training alleviates cardiac dysfunction and adverse remodeling via mitochondrial biogenesis and SIRT1/PGC-1α/PI3K/Akt signaling.
    Jia D; Hou L; Lv Y; Xi L; Tian Z
    J Cell Physiol; 2019 Dec; 234(12):23705-23718. PubMed ID: 31187505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caloric restriction ameliorates angiotensin II-induced mitochondrial remodeling and cardiac hypertrophy.
    Finckenberg P; Eriksson O; Baumann M; Merasto S; Lalowski MM; Levijoki J; Haasio K; Kytö V; Muller DN; Luft FC; Oresic M; Mervaala E
    Hypertension; 2012 Jan; 59(1):76-84. PubMed ID: 22068868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving concepts of oxidative stress and reactive oxygen species in cardiovascular disease.
    Chen K; Keaney JF
    Curr Atheroscler Rep; 2012 Oct; 14(5):476-83. PubMed ID: 22956414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The aging heart.
    Obas V; Vasan RS
    Clin Sci (Lond); 2018 Jul; 132(13):1367-1382. PubMed ID: 29986877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthy aging and myocardium: A complicated process with various effects in cardiac structure and physiology.
    Nakou ES; Parthenakis FI; Kallergis EM; Marketou ME; Nakos KS; Vardas PE
    Int J Cardiol; 2016 Apr; 209():167-75. PubMed ID: 26896615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Senescence marker protein 30 inhibits angiotensin II-induced cardiac hypertrophy and diastolic dysfunction.
    Misaka T; Suzuki S; Miyata M; Kobayashi A; Ishigami A; Shishido T; Saitoh S; Kubota I; Takeishi Y
    Biochem Biophys Res Commun; 2013 Sep; 439(1):142-7. PubMed ID: 23933320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural Bioactive Compounds As Protectors Of Mitochondrial Dysfunction In Cardiovascular Diseases And Aging.
    Arauna D; Furrianca M; Espinosa-Parrilla Y; Fuentes E; Alarcón M; Palomo I
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31766727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.